To access this element change to forms mode OFF
Grant Award View - GA217008
Treatments to expand regulatory T cells and/or deplete autoantibody...
GA ID:
GA217008
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
17-Oct-2021
Publish Date:
7-Feb-2022
Category:
Medical Research
Grant Term:
1-Jan-2022 to 31-Dec-2025
Value (AUD):
$98,470.73
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 20/21 1.1 Health and Medical Research
Grant Program:
Postgraduate Scholarships
Grant Activity:
Treatments to expand regulatory T cells and/or deplete autoantibody production in primary membranous nephropathy
Purpose:
Primary membranous nephropathy (pMN) is a kidney disease caused by antibodies that attack the kidney (autoantibody) and is often difficult to treat. We propose research into treatments in a rat model of pMN that target autoantibody-producing immune cells or promote regulatory immune cells, using manufactured immune cells and protein vaccination. We will also compare the immune cells in humans with pMN and healthy individuals to identify specific immune cells targetable using our new treatments.
GO ID:
GO Title:
2021 NHMRC Postgraduate Scholarship scheme
Internal Reference ID:
2021/GNT2014037
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of Sydney
Recipient ABN:
15 211 513 464
Grant Recipient Location
Suburb:
Camperdown
Town/City:
Camperdown
Postcode:
2050
State/Territory:
NSW
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
NSW
Postcode:
Country:
AUSTRALIA